Trial Profile
Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary)
- Indications Bacterial infections; Catheter infections
- Focus Pharmacokinetics
- 19 Apr 2011 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 19 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jul 2009 New trial record